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U-56324, a hypoglycemic agent derived from nicotinic acid, inhibited the activity of ATP-sensitive potassium channels in excised patches from 
mouse pancreatic B-cells. The effect of U-56324 on channel activity was reversible and concentration-dependent while it had no effect on single 
channel conductance. The positional isomer, U-59588, which has relatively little hypoglycemic activity, had no effect on channel properties. U- 
56324, at the same concentrations, had no effect on calcium-activated potassium channels. The basis for the potentially antidiabetic properties 
of U-56324 may therefore be due to direct and specific inhibition of ATP-sensitive potassium channels. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
Some members of the sulfonylurea class of com- 
pounds have proven invaluable as hypoglycemic agents 
in the treatment of non-insulin-dependent diabetes 
mellitus [l]. The basis for their clinical efficacy is 
thought to be due to inhibition of ATP-sensitive 
potassium channels (K(ATP) channels) in the plasma 
membranes of B-cells [2,3] and, following the resultant 
membrane depolarization and calcium influx through 
voltage-dependent calcium channels, in enhanced 
insulin secretion [4-71. A member of another class of 
compounds chemically related to nicotinic acid, U- 
56324 (1,2-Dihydro-2-oxo-6-(2,2_dimethylpropyl)-3- 
pyridinecarboxylic acid), possesses potent hypoglyce- 
mic activity and stimulates in vitro insulin secretion [8] 
(J.R. Colca, personal communication). By analogy 
with the effect of sulfonylureas on K(ATP) channel ac- 
tivity, we wished to test the hypothesis that the effects 
of U-56324 on blood glucose concentration and insulin 
secretion might be explained, at least in part, by effects 
on K(ATP) channels. We observed that U-56324 ex- 
hibited a direct, reversible, concentration-dependent i -
hibition of K(ATP) channel activity with no effect on 
the single conductance in excised patches from mouse 
pancreatic B-cells. 
Islets were isolated from the pancreases of adult female Swiss- 
Webster mice using collagenase digestion. Single islet cells were 
mechanically dispersed from the islets in a zero calcium buffer and 
subsequently plated on polylysine-coated cover slips in RPM1 1640 
culture medium. All data were obtained using cells cultured for one 
week or less. 
Following formation of a lo-40 Go seal, patches of membrane 
were excised in either the outside-out or inside-out configuration [9]. 
Single channel currents were recorded on VCR tape using a PCM data 
recorder and segments of data were digitized at 1 kHz after filtering 
at 0.3 kHz by an 8-pole Bessel filter. Amplitude histograms were con- 
structed from which average channel currents were calculated by in- 
tegrating the current over a time segment of data and dividing by the 
segment’s duration. Single channel conductances were determined 
from single channel I-V’s based on the amplitude histograms. 
Average channel activity was calculated by dividing average channel 
current by the single channel current amplitude [lo]. The effects of 
tested compounds were determined by normalizing the average 
K(ATP) channel activity in the presence of the drug to the mean of 
control (before drug application) and wash (following drug washout) 
episode average channel activity. 
The bath solution (pipette solution for the inside-out patches) had 
the following composition (in mM): 120 NaCl, 5 KCI, 3 CaC12, 2 
MgC12, 10 Hepes, pH = 7.2. The pipette solution (bath solution for 
inside-out patches) contained (in mM): 140 KCI, 1 EGTA, 1 MgC12, 
0.010 MgzATP, 10 Hepes, pH= 7.2. ATP (10 pM) was present to 
decrease the rate of rundown of K(ATP) channels commonly observ- 
ed in excised patches [l l-121. EGTA was included to chelate calcium 
and thereby suppress activity of K(Ca) channels (131. 
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U-56324 and U-59588 (1,2-Dihydro-2-oxo-4-(2,2-dimethylpropyl)- 
3-pyridinecarboxylic acid) were kindly provided by Upjohn (Kalama- 
zoo, Ml) and were dissolved in DMSO, and microliter aliquots were 
added to separate reservoirs containing the bath solution at the ap- 
propriate final concentrations. The final DMSO concentration was 
never more than 0.1% (v/v). 
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3. RESULTS 
K(ATP) channels were identified in outside-out pat- 
ches on the basis of their single channel conductance 
with assymetrical potassium concentrations across the 
patch (140 mM K+ in pipette, 5 mM K+ in bath, y = 
19.4 * 0.7 pS, measured between -40 and 0 mV 
pipette potential), inward-rectification, and the lack of 
voltage-dependence observed for their probability of 
opening [14]. Bath application of U-56324 (5 mM) 
resulted in a rapid (less than 10 seconds) decrease in 
channel activity that was somewhat more slowly reversi- 
ble (Fig. 1). U-56324 decreased the average K(ATP) 
channel activity in a concentration-dependent manner, 
but had no effect on the single channel current am- 
plitude at any of the concentrations tested (Fig. 2). The 
single channel conductance was not significantly af- 
fected by U-56324 (19.4 + 0.7 pS in control solution vs 
20.4 + 1.1 pS in U-56324, N = 6). The half-maximal 
effective concentration (ECSO) and Hill coefficient (n) 
for the effect of U-56324 on average channel activity 
were estimated by fitting the data in Fig. 2 with the 
following equation: 
WI” 
R = l - [Xl”+ [EC& 
where X is drug concentration and R average channel 
activity at that concentration normalized to the control 
channel activity. The best-fitting curve yielded an 
EGO= 233 FM and n = 0.58. The relatively low Hill 
coefficient could be due to negative cooperativity of 
drug binding or patch-to-patch variation of EGO. Fur- 
thermore, the effect of U-56324 on K(ATP) channel ac- 
tivity was not voltage-dependent when comparing 
results obtained at 0 mV and - 40 mV pipette potentials 
(Table I). 
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Fig. 1. The effect of U-56324 on K(ATP) channel activity in an 
outside-out patch. Control K(ATP) channel activity is shown in top 
trace. Middle record displays channel activity after U-56324 (5 mM) 
was applied, and the bottom trace was obtained following washout of 
U-56324. The dashed line in this and subsequent figures with traces 
denotes current level at which no channels are open. 0 mV pipette 
potential. 
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Fig. 2. Concentration-response curves for the effect of U-56324 on 
average channel activity (NPo, open squares) and channel current 
amplitude (i, closed circles) normalized to the mean of data obtained 
in control saline and following washout of U-56324. All data were 
taken from outside-out patches at 0 mV pipette potential. The dashed 
curve is the line-of-best-fit to the average channel activity using the 
equation given in the text. Each point is the mean of 6 patches, except 
for 5 mM U-56324 data, which is the mean of 5 patches. Error bars 
are SEM. 
Some patches were obtained that contained calcium- 
activated potassium channels, as determined by their 
relatively large current amplitudes and reversal poten- 
tial [ 131, and in which K(ATP) channel activity was ab- 
sent or had rundown. U-56324 (5 mM) had no apparent 
effect on the properties of these channels (data not 
shown). 
To determine whether the effect of U-56324 on 
K(ATP) channels is a general property of this class of 
compounds, the positional isomer U-59588, which has 
relatively little hypoglycemic activity [8], was also 
tested. U-59588 (5 mM) had no effect on average 
K(ATP) channel activity (Fig. 3). Higher concentra- 
tions of U-59588 were not tested. 
The effects of U-56324 were also tested in inside-out 
patches containing K(ATP) channels, as shown in Fig. 
4. In this experiment, ATP (2 mM) was bath-applied to 
establish channel identity, and it markedly reduced 
channel activity, U-56324 (5 mM) was subsequently ap- 
plied following washout of 2 mM ATP, and this 
Table 1 
Average K(ATP) channel activity, NPo, measured in 5 outside-out 
patches in control solution (mean of activity in equal duration 
segments of control and drug wash data) and with U-56324 at 0 mV 
and - 40 mV pipette potential. The concentrations of U-56324 are 50 
(n = 2). 50001=2), and 5000 (n = 1) WM. Values are mean f SEM 
Pipette potential Average channel activity Reduction in &‘Po 
WV) (NPo) WI 
Control U-56324 
-40 2.28 + 0.17 0.99 It 0.59 57 
0 2.68 ?z 0.34 0.99 & 0.61 63 
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Fig. 3. The positional isomer U-59588 does not decrease channel ac- 
tivity in outside-out patches. First record depicts control K(ATP) 
channel activity, and the second in the presence of U-59588 (5 mM). 
U-54324 (5 mM) was then applied to the patch and signifi~ntly reduc- 
ed channel activity (third trace). The fourth trace was obtained after 
washout of U-56324. 0 mV pipette potential. 
Control 
ATPfZmM) t I 
Wash 
I 4PA - 
ZYC 
Fig. 4. The effect of U-56324 on K(ATP) channel activity in an inside- 
out patch. Control K(ATP) channel activity is represented in the first 
trace, with the second obtained in the presence of ATP (2 mM). The 
third record was obtained following washout of ATP and the fourth 
after application of U-56324 (5 mM). The final trace depicts channel 
activity after washout of U-56324. 0 mV pipette potential. 
resulted in a reversible inhibition of channel activity. As 
with the outside-out patches, the drug reduced the pro- 
bability of opening and/or number of active K(ATP) 
channels, but had no effect on the channel current 
amplitude. 
4. DISCUSSION 
The data support the hypothesis that, as with sul- 
fonylurea compounds, the efficacy of U-56324 as a 
hypoglycemic agent and stimulator of insulin secretion 
are due, at least in part, to a reduction in K(ATP) chan- 
nel activity in pancreatic B-cells through a direct effect 
on these channels. U-56324 reduced K(ATP) channel 
activity over a concentration range similar to that for its 
concentration-dependent s imulation of in vitro insulin 
secretion from rat pancreatic islets (J.R. Colca, per- 
sonal communication). 
The effect of U-56324 on K(ATP) channels bears 
some similarities with the reported effects of sulfo- 
nylurea compounds. U-56324, like tolbutamide and 
glyburide, reduced K(ATP) channel activity without af- 
fecting the single channel current amplitude or conduc- 
tance through a direct action on the channel or closely 
associated protein 1151. Furthermore, the reduction in 
K(ATP) channel activity for both was not voltage- 
dependent [15] (Table I). Both U-56324 and the sul- 
fonylureas can inhibit K(ATP) channel activity from 
either side of the plasma membrane 1161, suggesting 
that they bind to sites within the plasma membrane. For 
the known potassium channel types in the B-cell mem- 
brane, the sulfonylureas are thought to act specifically 
on K(ATP) channels [3,15,17]. We observed no action 
of U-56324 on K(Ca) channels, but have not tested its 
possible effects on voltage-dependent, ‘delayed rec- 
tifier’ potassium channels [ 171. 
The estimated EGO for the reduction in K(ATP) 
channel activity by U-56324 (233 PM) is considerably 
higher than reported EC50 values for the sulfonylureas, 
which range from the low nanomolar to low micro- 
molar concentrations [3,18,19]. The concentra- 
tion-response data shown here were obtained solely 
from excised, outside-out patches. Differences in con- 
centration-response parameters for sulfonylurea in- 
hibition of K(ATP) channels between excised and 
intact-cell configurations have been reported [ 15,161, 
which may be due to the presence of ADP when the lat- 
ter configurations are used [20]. Whether U-56324 
binds to the same sites as the sulfonylureas to alter 
channel activity remains for future studies. 
In summary, U-56324, a compound derived from 
nicotinic acid that possesses hypoglycemic activity and 
stimulates insulin secretion, also directly inhibits the ac- 
tivity of K(ATP) channels from mouse pancreatic B- 
cells. Although other actions are possible, we speculate 
that, as with sulfonylurea compounds, the basis for 
these potentially antidiabetic effects resides in its 
specific and direct effect on K(ATP) channels. 
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